RCEL · AVITA Medical, Inc. · Analyst Estimates
$15.65
-1.06 (-6.34%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”View the 10-Q filed Aug 6, 2026
Market Cap
$484.01M
Shares
30.93M
Volume · Oct 30
597.05K
Avg daily vol (3M)
484.46K
Analyst Estimates
Compare analyst forecasts for AVITA Medical, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-20 20:44 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
AUD
Publication date not stated |
-1.34
|
0.42
|
1.48
|
4
|
0.25
|
0.25
|
0.25
|
0.076
|
0
|
0
|
1
|
4
|
|
Revenue
AUD
Publication date not stated |
123.74M
|
124.96M
|
126.59M
|
6
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
AUD
Publication date not stated |
-1.07
|
-0.60
|
0.096
|
4
|
-0.60
|
-0.60
|
-0.61
|
-0.86
|
0
|
1
|
1
|
3
|
|
Revenue
AUD
Publication date not stated |
150.45M
|
158.54M
|
170.67M
|
6
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
AUD
Publication date not stated |
-0.36
|
-0.29
|
-0.23
|
4
|
-0.29
|
-0.29
|
-0.29
|
-0.35
|
0
|
0
|
1
|
4
|
|
Revenue
AUD
Publication date not stated |
31.78M
|
32.11M
|
32.65M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
AUD
Publication date not stated |
-0.31
|
-0.24
|
-0.15
|
4
|
-0.24
|
-0.24
|
-0.24
|
-0.30
|
0
|
0
|
1
|
4
|
|
Revenue
AUD
Publication date not stated |
33.90M
|
34.53M
|
35.23M
|
4
|
— | — | — | — | — | — | — | — |